33 related articles for article (PubMed ID: 20399854)
1. Genistein stimulates MCF-7 breast cancer cell growth by inducing acid ceramidase (ASAH1) gene expression.
Lucki NC; Sewer MB
J Biol Chem; 2011 Jun; 286(22):19399-409. PubMed ID: 21493710
[TBL] [Abstract][Full Text] [Related]
2. Pubertal mammary development as a "susceptibility window" for breast cancer disparity.
Krisanits B; Randise JF; Burton CE; Findlay VJ; Turner DP
Adv Cancer Res; 2020; 146():57-82. PubMed ID: 32241392
[TBL] [Abstract][Full Text] [Related]
3. Genistein Promotes Proliferation of Human Cervical Cancer Cells Through Estrogen Receptor-Mediated PI3K/Akt-NF-κB Pathway.
Chen HH; Chen SP; Zheng QL; Nie SP; Li WJ; Hu XJ; Xie MY
J Cancer; 2018; 9(2):288-295. PubMed ID: 29344275
[TBL] [Abstract][Full Text] [Related]
4. Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects?
Lecomte S; Demay F; Ferrière F; Pakdel F
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28657580
[TBL] [Abstract][Full Text] [Related]
5. Impact of soy isoflavones on the epigenome in cancer prevention.
Pudenz M; Roth K; Gerhauser C
Nutrients; 2014 Oct; 6(10):4218-72. PubMed ID: 25322458
[TBL] [Abstract][Full Text] [Related]
6. Phytoestrogens and prevention of breast cancer: The contentious debate.
Bilal I; Chowdhury A; Davidson J; Whitehead S
World J Clin Oncol; 2014 Oct; 5(4):705-12. PubMed ID: 25302172
[TBL] [Abstract][Full Text] [Related]
7. Endocrine disruption of the epigenome: a breast cancer link.
Knower KC; To SQ; Leung YK; Ho SM; Clyne CD
Endocr Relat Cancer; 2014 Apr; 21(2):T33-55. PubMed ID: 24532474
[TBL] [Abstract][Full Text] [Related]
8. Does consuming isoflavones reduce or increase breast cancer risk?
Bondesson M; Gustafsson JA
Genome Med; 2010 Dec; 2(12):90. PubMed ID: 21176178
[TBL] [Abstract][Full Text] [Related]
9. Genistein, an epigenome modifier during cancer prevention.
Zhang Y; Chen H
Epigenetics; 2011 Jul; 6(7):888-91. PubMed ID: 21610327
[TBL] [Abstract][Full Text] [Related]
10. DING, a genistein target in human breast cancer: a protein without a gene.
Belenky M; Prasain J; Kim H; Barnes S
J Nutr; 2003 Jul; 133(7 Suppl):2497S-2501S. PubMed ID: 12840230
[TBL] [Abstract][Full Text] [Related]
11. Long-term genistein treatment of MCF-7 cells decreases acetylated histone 3 expression and alters growth responses to mitogens and histone deacetylase inhibitors.
Jawaid K; Crane SR; Nowers JL; Lacey M; Whitehead SA
J Steroid Biochem Mol Biol; 2010 Jun; 120(4-5):164-71. PubMed ID: 20399854
[TBL] [Abstract][Full Text] [Related]
12. Evidence that low-dose, long-term genistein treatment inhibits oestradiol-stimulated growth in MCF-7 cells by down-regulation of the PI3-kinase/Akt signalling pathway.
Anastasius N; Boston S; Lacey M; Storing N; Whitehead SA
J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):50-5. PubMed ID: 19406242
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells.
Aztopal N; Erkisa M; Erturk E; Ulukaya E; Tokullugil AH; Ari F
Chem Biol Interact; 2018 Jan; 280():51-58. PubMed ID: 29225137
[TBL] [Abstract][Full Text] [Related]
14. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.
Keen JC; Yan L; Mack KM; Pettit C; Smith D; Sharma D; Davidson NE
Breast Cancer Res Treat; 2003 Oct; 81(3):177-86. PubMed ID: 14620913
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
